World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
67
Citations
24310
World Ranking
6755
National Ranking
2027

Jerry L. McLaughlin publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Jerry L. McLaughlin sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 279 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Jerry L. McLaughlin D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jerry L. McLaughlin sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 67 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Jerry L. McLaughlin is affiliated with Purdue University West Lafayette in the United States. Their research intersects multiple disciplines within biochemistry, genetics, molecular biology, and medicine, with a particular emphasis on aging and longevity.

The scientist's recent work includes publications in notable journals such as Aging and Nature Biotechnology. Noteworthy papers are:

  • "Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity" (2024, Aging)
  • "Defining a longevity biotechnology company" (2023, Nature Biotechnology)

Their research contributions frequently appear in venues focused on aging and biotechnology, which align with the subfields they explore. These subfields include aging, geriatrics and gerontology, neuropsychology and physiological psychology, molecular biology, and public health, environmental, and occupational health.

Jerry L. McLaughlin's expertise encompasses several key fields of study:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

The scientist's work spans a range of topics related to aging, longevity, and biotechnology. Principal topics covered by their publications are:

  • Genetics, Aging, and Longevity in Model Organisms
  • Frailty in Older Adults
  • Aging and Gerontology Research
  • CRISPR and Genetic Engineering
  • Biotechnology and Related Fields

Collaborations and coauthorships have been an integral part of their research activities. Frequent coauthors include:

  • David Sinclair
  • Eric Morgen
  • James Peyer
  • Joan B. Mannick
  • Joe Betts-LaCroix

Best Publications

  • Brine shrimp: a convenient general bioassay for active plant constituents.

    Brian N. Meyer;N. R. Ferrigni;J. E. Putnam;Linda B. Jacobsen

  • Annonaceous Acetogenins: Recent Progress

    Feras Q. Alali;Xiao-Xi Liu;Jerry L. McLaughlin

  • Annonaceous acetogenins: a review.

    J. K. Rupprecht;Yu-Hua Hui;J. L. Mclaughlin

  • Recent advances in annonaceous acetogenins

    Lu Zeng;Qing Ye;Nicholas H. Oberlies;Guoen Shi

  • Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol.

    J M Oliver;D L Burg;B S Wilson;J L McLaughlin

  • A blind comparison of simple bench-top bioassays and human tumour cell cytotoxicities as antitumor prescreens

    J. E. Anderson;C. M. Goetz;J. L. McLaughlin;M. Suffness

  • Paw Paw and Cancer: Annonaceous Acetogenins from Discovery to Commercial Products⊥

    Jerry L. McLaughlin

  • Kinase inhibitors from Polygonum cuspidatum

    Gamini S. Jayatilake;Hiranthi Jayasuriya;Eung-Seok Lee;Nuphavan M. Koonchanok

  • Chemical Constituents of the Fruits of Morinda citrifolia (Noni) and Their Antioxidant Activity

    Bao Ning Su;Alison D. Pawlus;Hyun Ah Jung;William J. Keller

  • Determination of Absolute Configuration of Stereogenic Carbinol Centers in Annonaceous Acetogenins by 1H- and 19F-NMR Analysis of Mosher Ester Derivatives

    Matthew J. Rieser;Matthew J. Rieser;Yu Hua Hui;Yu Hua Hui;J. Kent Rupprecht;J. Kent Rupprecht;John F. Kozlowski;John F. Kozlowski

  • Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum.

    Hiranthi Jayasuriya;Nuphavan M. Koonchanok;Robert L. Geahlen;Jerry L. McLaughlin

  • Structure−Activity Relationships of Diverse Annonaceous Acetogenins against Multidrug Resistant Human Mammary Adenocarcinoma (MCF-7/Adr) Cells

    Nicholas H. Oberlies;Ching-jer Chang;Jerry L. McLaughlin

  • Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor.

    Robert L. Geahlen;Jerry L. McLaughlin

  • Mode of action of bullatacin, a potent antitumor acetogenin: Inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes.

    D J Morré;R de Cabo;C Farley;N H Oberlies

  • Comparison of HPLC methods for determination of anthocyanins and anthocyanidins in bilberry extracts.

    Zhe Zhang;Xiaolan Kou;Ken Fugal;Jerry McLaughlin

  • Additional bioactive compounds and trilobacin, a novel highly cytotoxic acetogenin, from the bark of Asimina triloba.

    Gengxian Zhao;Yuhua Hui;J. K. Rupprecht;J. L. Mclaughlin

  • Annonaceous acetogenins: An updated review

    Xin‐Ping Fang;Matthew J. Rieser;Zhe‐Ming Gu;Geng‐Xian Zhao

  • Two new styryl lactones, 9-deoxygoniopypyrone and 7-epi-goniofufurone, from Goniothalamus giganteus.

    Xin-Ping Fang;Jon E. Anderson;Ching-Jer Chang;Jerry L. McLaughlin

  • New inhibitors of complex I of the mitochondrial electron transport chain with activity as pesticides.

    Robert M. Hollingworth;Kabeer I. Ahammadsahib;G. Gadelhak;J. L. McLaughlin

  • The Annonaceous Acetogenin Bullatacin Is Cytotoxic against Multidrug Resistant Human Mammary Adenocarcinoma Cells

    Nicholas H. Oberlies;Vicki L. Croy;Marietta L. Harrison;Jerry L. McLaughlin

  • Muricatacin: A simple biologically active acetogenin derivative from the seeds of annona muricata (annonaceae)

    Matthew J. Rieser;John F. Kozlowski;Karl V. Wood;Jerry L. McLaughlin

Frequent Co-Authors

David L. Smith
David L. Smith University of Nebraska–Lincoln
Nicholas H. Oberlies
Nicholas H. Oberlies University of North Carolina at Greensboro
Robert L. Geahlen
Robert L. Geahlen Purdue University West Lafayette
Phillip E. Fanwick
Phillip E. Fanwick Purdue University West Lafayette
David L. Smith
David L. Smith University of Washington
David E. Nichols
David E. Nichols Purdue University West Lafayette
A. Douglas Kinghorn
A. Douglas Kinghorn The Ohio State University
Bernard J. R. Philogène
Bernard J. R. Philogène University of Ottawa
D. James Morré
D. James Morré Purdue University West Lafayette
Murray B. Isman
Murray B. Isman University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry opens doors to various related fields and career pathways. For those interested in law and regulation aspects connected to chemistry, obtaining the best online associates in criminal justice can provide valuable interdisciplinary knowledge, especially in forensic chemistry.

Another pathway involves support roles within the legal framework. Exploring a paralegal degree offers opportunities to work closely with intellectual property, patents, or compliance related to chemical inventions and research.

For those drawn to the commercial side of chemistry, becoming a pharmaceutical sales representative can be rewarding. Understanding how much do pharmaceutical sales reps make provides insight into this lucrative career path that blends science knowledge with business skills.

Finally, many chemistry graduates opt for advanced education to become licensed pharmacists. This demands awareness of how much schooling to be a pharmacist, which typically involves extensive study but leads to stable and rewarding careers in healthcare.

Best Scientists Citing Jerry L. McLaughlin

Recently Published Articles